Catalyst Wire Dossier Catalyst Wire Dossier

GSK1265744 (cabotegravir)

cabotegravir · GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GSK1265744 (cabotegravir), covering 2010-10-15 to 2010-10-15. Get the full timeline:

Most recent: Clinical Trial Update: A Healthy Volunteer And Patient Study To Assess The Safety, Tolerability And Pharmacokinetics Of GSK1265744 [Phase 1]

See pricing